Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
暂无分享，去创建一个
H. Yoshiji | K. Chayama | Y. Karino | T. Pilot‐Matias | Y. Takei | Y. Eguchi | M. Burroughs | Y. Kawakami | W. Xie | H. Kumada | R. Redman | Ken Sato | F. Suzuki | Koji Kato | R. Oberoi | D. Pugatch | Tsunamasa Watanabe | A. Naganuma | M. Seike | P. Krishnan | T. Atarashi | K. Alves